Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetic nephropathy: common questions.

Micah L Thorp1

  • 1Lake Road Nephrology Clinic, Milwaukie, Oregon 97267, USA. micahthorp@comcast.net

American Family Physician
|July 23, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of a Kidney Replacement Therapy Risk Score Developed in Kaiser Permanente Northwest vs Estimated Glomerular Filtration Rate in Advanced Chronic Kidney Disease Using Decision Curve Analysis.

The Permanente journal·2022
Same author

Physician adjudication of angioedema diagnosis codes in a population of patients with heart failure prescribed angiotensin-converting enzyme inhibitor therapy.

Pharmacoepidemiology and drug safety·2021
Same author

A Quality Improvement Initiative Targeting Chronic Kidney Disease Metrics Through Increased Urinary Albumin Testing.

The Permanente journal·2021
Same author

Predicted risk of renal replacement therapy at arteriovenous fistula referral in chronic kidney disease.

The journal of vascular access·2020
Same author

Association of Proteinuria with Central Venous Catheter Use at Initial Hemodialysis.

The Permanente journal·2017
Same author

Predicting 5-Year Risk of RRT in Stage 3 or 4 CKD: Development and External Validation.

Clinical journal of the American Society of Nephrology : CJASN·2016
Same journal

For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

American family physician·2026
Same journal

Nausea and Vomiting During Pregnancy.

American family physician·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

American family physician·2026
Same journal

Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

American family physician·2026
Same journal

Overscreening Leads to Overdiagnosis of MASLD.

American family physician·2026
Same journal

Type 2 Diabetes: Outpatient Insulin Management.

American family physician·2026
See all related articles

Diabetic nephropathy (kidney disease) screening involves urine tests for microalbuminuria. Early detection and management of blood pressure and glucose, along with specific medications, can slow disease progression.

Area of Science:

  • Nephrology
  • Endocrinology
  • Diabetology

Background:

  • Diabetic nephropathy affects 20-30% of diabetes patients, a leading cause of kidney failure.
  • Early detection involves identifying microalbuminuria, indicated by low albumin levels in urine.

Purpose of the Study:

  • To outline the screening, diagnosis, and management of diabetic nephropathy.
  • To emphasize the importance of early intervention in slowing disease progression.

Main Methods:

  • Screening for microalbuminuria using the albumin-to-creatinine ratio in spot urine tests.
  • Diagnosis requires two out of three positive tests over 3-6 months.
  • Management includes optimizing blood pressure and glycemic control.

Main Results:

Related Experiment Videos

  • Optimizing blood pressure (≤130/80 mm Hg) and glycemic control slows diabetic nephropathy progression.
  • Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial for patients with diabetes and microalbuminuria or hypertension.
  • Nondihydropyridine calcium channel blockers are alternatives if ACE inhibitors/ARBs are not tolerated.

Conclusions:

  • Early detection of microalbuminuria is crucial for managing diabetic nephropathy.
  • Aggressive management of hypertension and hyperglycemia, alongside ACE inhibitors/ARBs, is key to preserving kidney function.
  • Careful monitoring of serum creatinine and potassium is essential when using ACE inhibitors/ARBs.